Entrada Therapeutics (TRDA) P/E (2021 - 2026)
Entrada Therapeutics (TRDA) P/E from Dec 31, 2021 to Jul 21, 2026. The TTM Entrada Therapeutics (TRDA) P/E is -1.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Entrada Therapeutics (TRDA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.49 | -45.36% |
| 2025 | -2.73 | -128.95% |
| 2024 | 9.42 | -143.91% |
| 2023 | -21.46 | +348.82% |
| 2022 | -4.78 | -83.50% |
| 2021 | -28.97 | N/A |
Comparison Entrada Therapeutics (TRDA) P/E with competitors
Entrada Therapeutics (TRDA) P/E is -1.49.